Intrinsic Value of S&P & Nasdaq Contact Us

Frequency Therapeutics, Inc. FREQ NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.40
+367.3%

Financial Health Score — FREQ

Frequency Therapeutics, Inc. (FREQ) has an overall financial health rating of B with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-11-03.

B
Overall Rating
2023-11-03

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-11-03 B -/5 -/5 -/5 -/5 -/5 -/5
2023-11-02 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-11-01 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-31 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-30 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-27 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-26 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-25 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-24 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-23 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-20 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-10-19 B+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message